期刊文献+

激素联合静脉环磷酰胺冲击治疗对Ⅳ型及Ⅳ+Ⅴ型狼疮性肾炎的疗效

Therapeutic outcomes of hormone combined with intravenous cyclophosphamide in patients with class Ⅳ and class Ⅳ+Ⅴlupus nephritis
下载PDF
导出
摘要 目的:观察并评价激素联合静脉环磷酰胺(CTX)冲击治疗对Ⅳ型及Ⅳ+Ⅴ型狼疮性肾炎(LN)的治疗作用。方法:总结我院6年来收治Ⅳ型及Ⅳ+Ⅴ型LN各7例,所有患者均采用激素联合静脉CTX冲击治疗。结果:治疗后Ⅳ型LN组24h尿蛋白定量、血清白蛋白(ALB)、血清肌酐(SCr)、血沉(ESR)、血清补体C3及狼疮活动分数(SLE-DAI)均显著改善(P<0.05或P<0.01);Ⅳ+Ⅴ型LN组除24h尿蛋白定量外,其他指标均显著改善(P<0.01)。两治疗组总有效率相似(P>0.05)。结论:激素联合静脉环磷酰胺(CTX)冲击治疗对Ⅳ型LN及Ⅳ+Ⅴ型LN均有效。 Objective: To observe and evaluate the effect and safety of hormone therapy combined with intravenous cyclophosphamide (CTX) in patients with class IV and class IV+Vlupus nephritis(LN). Methods:The clinical data and outcomes were retrospectively analyzed in 14 patients ( class Ⅳlupus nephritis 7, Ⅳ +Ⅴupus nephritis 7 ,respectively) undergone hormone therapy in combination with intravenous CTX over the 6 years in our hospital. Results:In patients with class IV LN,the involved indicators and indexes were improved significantly with regard to 24-hour urinary protein,serum albumin (ALB),serum creatininc (SCr),erythrocyte sedimentation rate (ESR) , serum complement C3 and SLE-DAI after the therapy described above (P 〈 0. 05 or P 〈 0.01 ) , and the same resuits were found in the patients with Ⅳ +Ⅴ LN except for 24 h urinary protein (P 〈 0.01 ). The therapeutic outcomes were approximately identical in the two groups ( P 〉 0. 05 ). Conclusion : Hormone therapy combined with intravenous CTX produces equivalent effect on patients with class Ⅳ or Ⅳ +Ⅴ lupus nephritis.
出处 《皖南医学院学报》 CAS 2009年第6期421-424,共4页 Journal of Wannan Medical College
关键词 狼疮性肾炎 激素 环磷酰胺 临床疗效 不良反应 lupus nephritis hormone cyclophosphamide clinical efficacy adverse reaction
  • 相关文献

参考文献10

  • 1王海燕.系统性红斑性狼疮性肾炎[M]//王海燕.肾脏病学.第2版.北京:人民卫生出版社,1996:861.
  • 2BOMBARDIER C, GLADMAN DD, UROWITZ MB, et al. A disease activity index for lupus patient. The committee on prognosis studies in SLE [ J]. Arthritis Rheum, 1992,35 (6) :630 - 640.
  • 3刘志红,黎磊石.甲基强的松龙冲击疗法的理论与实践[J].肾脏病与透析肾移植杂志,2002,11(5):435-436. 被引量:20
  • 4KARIM Y, D'CRUZ DP. The NIH pulse cyclophosphamide regime: the end of an era[ J] ? Lupus,2004,13 ( 1 ) : 1 - 3.
  • 5陈战瑞,赵铖,廖蕴华,伍巧源.糖皮质激素联合环磷酰胺治疗Ⅳ型狼疮性肾炎的疗效观察[J].广西医科大学学报,2006,23(2):286-287. 被引量:2
  • 6NAJAFI CC,KORBET SM,LEWIS EJ,et al. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis[ J]. Kidney Int,2001,59(6) :2156 - 2163.
  • 7Sloan RP,Schwartz MM, Korbet SM,et al. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group[ J]. J Am Soc Nephrol, 1996,7 ( 2 ) : 299 - 305.
  • 8崔太根,侯凡凡,倪兆慧,陈香美,张凤山,朱彤莹,赵学智,鲍春德,赵明辉,王国保,钱家麒,蔡广研,李英楠,陆福明,梅长林,邹万忠,王海燕.来氟米特联合糖皮质激素治疗增殖型狼疮性肾炎的多中心对照临床试验研究[J].中华内科杂志,2005,44(9):672-676. 被引量:104
  • 9HAO BAO,ZHI-HONG LIU, HONG-LANG XIE,et al. Successful treatment of class Ⅴ + Ⅳ lupus nephritis with multitarget therapy [J]. J Am Soc Nephrol,2008,9(10) :2001 -2010.
  • 10郑为超,胡顺金,方琦,张桃艳,张莉,任克军.六味地黄丸对激素及环磷酰胺治疗狼疮性肾炎的干预作用[J].中国中西医结合杂志,2005,25(11):983-985. 被引量:16

二级参考文献19

  • 1崔太根,侯凡凡,倪兆慧,陈香美,张凤山,朱彤莹,赵学智,鲍春德,赵明辉,王国保,钱家麒,蔡广研,李英楠,陆福明,梅长林,邹万忠,王海燕.来氟米特联合糖皮质激素治疗增殖型狼疮性肾炎的多中心对照临床试验研究[J].中华内科杂志,2005,44(9):672-676. 被引量:104
  • 2Flanc RS, Roberts MA, Strippoli GF, et al.Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.Am J Kidney Dis,2004,43:197-208.
  • 3Breedveld FC, Dayer JM.Leflunomide: mode of action in the treatment of rheumatoid arthritis.Ann Rheum Dis, 2000,59:841-849.
  • 4Li EK, Tam LS, Tomlinson B.Leflunomide in the treatment of rheumatoid arthritis.Clin Ther,2004,26: 447-459.
  • 5Remer CF, Weisman MH, Wallace DJ.Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.Lupus,2001,10:480-483.
  • 6Tam LS, Li EK, Wong CK, et al.Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.Lupus,2004,13:601-604.
  • 7Levey AS, Lan SP, Corwin HL, et al.Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.Ann Intern Med,1992,116:114-123.
  • 8Smolen JS, Kalden JR, Scott DL, et al.Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.Lancet,1999,353:259-266.
  • 9Kalden JR, Schattenkirchner M, Sorensen H, et al.The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.Arthritis Rheum,2003,48:1513-1520.
  • 10Tan EM ,Cohen AS ,Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982,25:1271-1277.

共引文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部